All In MedTech

FDA Clearance Tracker · P080025-S046

MEDTRONIC INTERSTIM THERAPY SYSTEM

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Apr 18, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080025-S046
Device name
MEDTRONIC INTERSTIM THERAPY SYSTEM
Applicant location
Minneapolis, MN
Received
Feb 6, 2013
Decided
Apr 18, 2014
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P080025

Device type

Device class
Class III
Regulation
21 CFR 876.5270

Every decision under product code QON

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MEDTRONICS VERIFY EVALUATION SYSTEM, WHICH IS A TEST STIMULATION SYSTEM CONSISTING OF THE MODEL 3537 CONTROLLER, THE MODEL 3531 VERIFY EXTERNAL NEUROSTIMULATOR (ENS), AND ASSOCIATED CABLES (MODELS 3575 AND 3576) AND ACCESSORIES.

Source documents

Other decisions for Medtronic Neuromodulation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.